APDN Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

September 4, 2024

Read More

Applied DNA Submits Validation Package to New York State Department of Health toExpand Linea Mpox Virus 1.0 Assay to Mpox Clade I

August 23, 2024

Read More

APDN To Submit Application to NYS Dept of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

August 23, 2024

Read More

APDN Announces Third Quarter Fiscal Year 2024 Financial Results

August 8, 2024

Read More

APDN to Report FQ3’24 Advisory: Thursday, August 8, 2024

August 7, 2024

Read More

APDN to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4 th Presentation Annual mRNA-based Therapeutics Summit

July 29, 2024

Read More

Indus, APDN Multi-Year Agreement for CertainT Cotton Traceability

July 25, 2024

Read More

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract

July 18, 2024

Read More

APDN, Alphazyme Conclude Linea™ RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea™ IVT Platform Economics

June 20, 2024

Read More